05 March 2012

Angel Biotechnology Holdings plc

("Angel" or "the Company")

Appointment of Dr. Stewart White as Acting CEO

Angel Biotechnology Holdings plc, (AIM:ABH), the biopharmaceutical contract manufacturer, is about to enter what the Directors believe is an unprecedented period of growth. The Cramlington facilty will shortly come on line for non-GMP (KOSDAQ: 018290.KQ - news) activities and we are working on a number of other projects. This means that we must re-structure our staff around the needs of the business and we expect to make a number of new appointments to augment our existing senior team.

As part of this re-structuring activity the Board is pleased to announce the appointment of Dr. Stewart White as Acting CEO following the decision of the COO, Mr. Gordon Sherriff to leave the Company. Dr. White was recruited into his present position as Commercial Director with a view to his progression to becoming CEO in due course. Stewart has made a significant impact on the business since joining Angel in December 2011 and the Board has every confidence in Stewart's ability to fulfill this new role and for the appointment to be made permanent after a period of evaluation.

Dr. Paul Harper, Executive Chairman, said: "Stewart has made an excellent start in his role at Angel, bringing drive, focus and leadership in his current role and more broadly across the business. During Gordon Sherriff's period of absence, Stewart has assumed a broad range of responsibilities alongside Lorna Peers, our FD, and myself. The senior staff have responded magnificently to the new challenges and greater responsibility supported by a steady stream of new appointments at both Pentlands and Cramlington."

For further information:

Angel Biotechnology Holdings plc

Lorna Peers, Finance Director +44 (0) 131 445 6077

Read more here:
Angel Biotechnology - Appointment of acting CEO